No Data
San Nova Pharmaceutical-B (02257.HK): Lu Yang and Sheng Muxian resign as members of the investigation committee.
GraceAlliance October 29th, Shengnuo Pharmaceuticals-B (02257.HK) announced that the board of directors has established an investigation committee, chaired by the chairman of the board and executive director Lu Yang, along with all independent non-executive directors, namely Chang Hai, Huang Mengying, and Shengmuxian, to investigate the incident that the issuer of the private placement bonds invested by the fund may default, expecting a significant adverse change in the net asset value of the fund. The board of directors has received notifications from Lu Yang and Shengmuxian voluntarily resigning as members of the investigation committee to devote more time to their respective duties prior to being appointed as members of the investigation committee, effective October 29, 2024.
San Nuo Medicine-B (02257): Pan Honghui appointed as an executive director.
San Nova Pharmaceuticals-B (02257) announced that Dr. Pan Honghui has been appointed as an executive director, effective from October 2024...
Express News | Sirnaomics Ltd - Poon Hung Fai Appointed as Executive Director
Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development
Sanofi-Aventis(B-02257) has provided supplementary explanations on the subscription of shares to be issued, and will resume trading on October 4th.
Sanofi-B (02257) announced that, according to the announcement on October 3, 2024, the company (as the issuer) entered into a...
Express News | Sirnaomics Ltd - Application Made to Stock Exchange for Resumption of Trading in Shares W.e.f. 9:00 A.m. on Oct 4
Press Release: Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer
No Data
No Data
